Fahimeh LaviArab

Dr. Fahimeh LaviArab

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2024 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
AGAlireza Ghasempour
Alireza Ghasempour
HDHamideh Dehghan
Hamideh Dehghan
MMMahmoud Mahmoudi
Mahmoud Mahmoudi
FLFahimeh LaviArab
Fahimeh LaviArab
Since wound healing is one of the most important medical challenges and common dressings have not been able to manage this challenge well today, efforts have been increased to achieve an advanced dressing. Mesenchymal stem cells and exosomes derived from them have shown high potential in healing and regenerating wounds due to their immunomodulatory, anti-inflammatory, immunosuppressive, and high regenerative capacities. However, challenges such as the short life of these cells, the low durability of these cells in the wound area, and the low stability of exosomes derived from them have resulted in limitations in their use for wound healing. Nowadays, different scaffolds are considered suitable biomaterials for wound healing. These scaffolds are made of natural or synthetic polymers and have shown promising potential for an ideal dressing that does not have the disadvantages of common dressings. One of the strategies that has attracted much attention today is using these scaffolds for seeding and delivering MSCs and their exosomes. This combined strategy has shown a high potential in enhancing the shelf life of cells and increasing the stability of exosomes. In this review, the combination of different scaffolds with different MSCs or their exosomes for wound healing has been comprehensively discussed.

29 April 2023 in Archives of Virology
Verified
Journal Article
Open access
PDF file
TNTahereh Nazary
Tahereh Nazary
AAAzin Aghamajidi
Azin Aghamajidi
MDMaryam Dorfaki
Maryam Dorfaki
FKFatemeh Keshavarz
Fatemeh Keshavarz
ZSZahra Shafaghat
Zahra Shafaghat
RJReza Jafari
Reza Jafari
B lymphocytes play a vital role in the human defense against viral infections by producing specific antibodies. They are also critical for the prevention of infectious diseases by vaccination, and their activation influences the efficacy of the vaccination. Since the beginning of coronavirus disease 2019 (COVID-19), which became the main concern of the world health system, many efforts have been made to treat and prevent the disease. However, for the development of successful therapeutics and vaccines, it is necessary to understand the interplay between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, and the immune system. The innate immune system provides primary and nonspecific defense against the virus, but within several days after infection, a virus-specific immune response is provided first by antibody-producing B cells, which are converted after the resolution of disease to memory B cells, which provide long-term immunity. Although a failure in B cell activation or B cell dysfunction can cause a severe form of the disease and also lead to vaccination inefficiency, some individuals with B cell immunodeficiency have shown less production of the cytokine IL-6, resulting in a better disease outcome. In this review, we present the latest findings on the interaction between SARS-CoV-2 and B lymphocytes during COVID-19 infection.

28 October 2024 in Applied Food Research
Verified
Journal Article
Open access
FMFatemeh Mosallaie
Fatemeh Mosallaie
MPMotahare Pirnia
Motahare Pirnia
ZDZahra Dehghan
Zahra Dehghan
FFFereshteh Falah
Fereshteh Falah
RSReihaneh Sabbaghzadeh
Reihaneh Sabbaghzadeh
AVAlireza Vasiee
Alireza Vasiee

20 September 2020 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
FYForouzan Yousefi
Forouzan Yousefi
FLFahimeh LaviArab
Fahimeh LaviArab
MRMaryam Rastin
Maryam Rastin
NTNafiseh S. Tabasi
Nafiseh S. Tabasi
KNKarim Nikkhah
Karim Nikkhah
MMMahmoud Mahmoudi
Mahmoud Mahmoudi

23 July 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MSMaryam Sadri
Maryam Sadri
SHSahel Heidari
Sahel Heidari
AFArezoo Faridzadeh
Arezoo Faridzadeh
MRMona Roozbehani
Mona Roozbehani
STShirin Toosi
Shirin Toosi
FFFatemeh Faraji
Fatemeh Faraji
Immunotherapy has improved cancer treatment based on investigations of tumor immune escape. Manipulation of the immune system stimulates antitumor immune responses and blocks tumor immune escape routes. Genetically adoptive cell therapy, such as T cells, has yielded promising results for hematologic malignancies, but their application to solid tumors has been challenging. Macrophages have a wide broad of capabilities in regulating immune responses, homeostasis, and tissue development, as well as the ability to phagocyte, present antigens, and infiltrate the tumor microenvironment (TME). Given the importance of macrophages in cancer development, they could serve as novel tool for tumor treatment. Therefore, macrophages are used in different formats for direct and indirect targeting of tumor cells. This review summarized the available data on the various applications of macrophages in cancer immunotherapy.

2 May 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
FLFahimeh LaviArab
Fahimeh LaviArab
AHAkram Hoseinzadeh
Akram Hoseinzadeh
FHFatemeh Hafezi
Fatemeh Hafezi
FMFatemeh Sadat Mohammadi
Fatemeh Sadat Mohammadi
FZFarid Zeynali
Farid Zeynali
ARAmirreza Rostami
Amirreza Rostami